Status:

COMPLETED

Examining the Effect of Ondansetron on Bowel Prep Success

Lead Sponsor:

State University of New York - Downstate Medical Center

Conditions:

Abdominal Pain

Inflammatory Bowel Diseases

Eligibility:

All Genders

2-20 years

Phase:

PHASE4

Brief Summary

This is a pilot randomized-controlled trial assessing the utility of ondansetron for improving pediatric pre-colonoscopy bowel prep outcomes using the boston bowel preparation score, as well as assess...

Detailed Description

The study will compare two approaches to pre-colonoscopy cleanout, one with traditional laxatives only, and one with laxatives + anti-emetic therapy. The medication to be added will be Ondansetron (br...

Eligibility Criteria

Inclusion

  • Age \>2, \<20
  • clinically indicated for a colonoscopy

Exclusion

  • known arrhythmia or long QT

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2023

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT05439772

Start Date

January 1 2021

End Date

July 1 2023

Last Update

October 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SUNY Downstate University Hospital of Brooklyn

Brooklyn, New York, United States, 11203

Examining the Effect of Ondansetron on Bowel Prep Success | DecenTrialz